[Application of tumour markers in clinical practice].
Usefully requesting and applying serum tumour markers in diagnosis and treatment can be difficult. It should be noted that tumour markers are used for varying purposes: screening, diagnosis, staging and prognostic evaluation, detection of recurrence and treatment monitoring. Due to the poor sensitivity and specificity of current tumour markers, most are not suitable for screening an asymptomatic population. Further, the benefits of an improved prognosis by early detection should be weighed against a poorer quality of life and the cost of substantial over-diagnosis and over-treatment. Serum tumour markers are particularly applicable in treatment monitoring and detection of recurrence. Sometimes they can be used to support the diagnostic process and give useful prognostic information.
Keuren
Jeffrey F W
JF
Atrium Medisch Centrum, afd. Klinische Chemie, Heerlen, The Netherlands. j.keuren@atriummc.nl
Thomas
Chris M G
CM
Bonfrèr
J M G Hans
JM
Sweep
C G J Fred
CG
Boonstra
Joke G
JG
D014408:Biomarkers, Tumor / Q000097:blood*; D055088:Early Detection of Cancer; D006801:Humans; D009367:Neoplasm Staging; D009369:Neoplasms / Q000097:blood* / Q000175:diagnosis; D011379:Prognosis; D012680:Sensitivity and Specificity
D014408:Biomarkers, Tumor